Results 81 to 90 of about 29,622 (267)
ESC Heart Failure, EarlyView.Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami +11 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims The inflammatory profile of cardiogenic shock (CS) after myocardial infarction affects outcomes; however, little is known about the impact of inflammatory changes in CS caused by acute decompensated heart failure (ADHF‐CS). We measured levels of inflammatory cytokines in patients with ADHF‐CS admitted to a cardiac intensive care unit ...
Darshan H. Brahmbhatt +9 more
wiley +1 more source
Clinical Physiology and Functional Imaging, Volume 43, Issue 1, Page 47-57, January 2023., 2023 Abstract Patients requiring temporal or permanent catheter or arterio‐venous fistula (AVF) for haemodialysis may be in challenging situation, if they are cardiovascular implantable electronic devices (CIED) carriers. Materials and Methods The authors analysed preoperative venogrphies of 3100 patients referred for transvenous lead extraction for a ...
Marek Czajkowski +6 more
wiley +1 more source
Temporal profiling of M‐TEER‐related complications
ESC Heart Failure, EarlyView.Abstract Aims Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) is known for its low complication rates. However, the optimal level and duration of post‐procedural care remain unclear. This study aimed to identify the specific timeframe of post‐procedural complications following M‐TEER.
Jafer Haschemi +8 more
wiley +1 more source
European Journal of Clinical Investigation, Volume 53, Issue 1, January 2023., 2023 Abstract Background The number of patients with cardiac implantable electronic devices (CIEDs) undergoing radiotherapy (RT) for cancer treatment is growing. At present, prevalence and predictors of RT‐induced CIEDs malfunctions are not defined. Methods Systematic review and meta‐analysis conducted following the PRISMA recommendations.
Vincenzo Livio Malavasi +10 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani +17 more
wiley +1 more source
Journal of Cardiovascular Electrophysiology, Volume 33, Issue 12, Page 2606-2613, December 2022., 2022 Abstract Introduction Atrioventricular (AV)‐node ablation (AVNA) is a common therapy option for rate control strategy of permanent atrial fibrillation (AF). We hypothesized that isolation of the AV nodal isolation (AVNI) is associated with a more frequent preservation of an adequate escape rhythm compared to AVNA.
Lisa Lemke +11 more
wiley +1 more source
P-157 Difference in response to cardiac resynchronization therapy between patients in sinus rhythm or with chronic atrial fibrillation [PDF]
, 2003 Sander G. Molhoek +6 more
openalex +3 more sources
Cardiac Resynchronization Therapy: Who Benefits?
Annals of Global Health, 2014 Background: Cardiac resynchronization therapy (CRT) has been well established in multiple large trials to improve symptoms, hospitalizations, reverse remodeling, and mortality in well-selected patients with heart failure when used in addition to optimal ...
Jason S. Chinitz +4 more
doaj +1 more source